Multi-Mechanistic and Therapeutic Exploration of Nephroprotective Effect of Traditional Ayurvedic Polyherbal Formulation Using In Silico, In Vitro and In Vivo Approaches
Authors
Gaurav
Centre of Excellence (CoE) in Unani Medicine (Pharmacognosy and Pharmacology), Bioactive Natural Product Laboratory, Jamia Hamdard, New Delhi 110062, India
Mohammad Khan
Centre of Excellence (CoE) in Unani Medicine (Pharmacognosy and Pharmacology), Bioactive Natural Product Laboratory, Jamia Hamdard, New Delhi 110062, India
Sultan Zahiruddin
Centre of Excellence (CoE) in Unani Medicine (Pharmacognosy and Pharmacology), Bioactive Natural Product Laboratory, Jamia Hamdard, New Delhi 110062, India
Parakh Basist
Centre of Excellence (CoE) in Unani Medicine (Pharmacognosy and Pharmacology), Bioactive Natural Product Laboratory, Jamia Hamdard, New Delhi 110062, India
Sayeed Ahmad
Centre of Excellence (CoE) in Unani Medicine (Pharmacognosy and Pharmacology), Bioactive Natural Product Laboratory, Jamia Hamdard, New Delhi 110062, India
Based on traditional therapeutic claims, NEERI KFT (a traditional Ayurvedic polyherbal preparation) has been innovatively developed in recent time on the decades of experience for treating kidney dysfunction. Due to the lack of scientific evidence, the present investigations are needed to support the rationale use of NEERI KFT. Considering the facts, the study investigated the nephroprotective effect of NEERI KFT against kidney dysfunction using in silico, in vitro and in vivo approaches. In this study, phytochemical and network pharmacology studies were performed for the developed formulation to evaluate the molecular mechanism of NEERI KFT in the amelioration of kidney disease. In vitro nephroprotective and antioxidant effect of NEERI KFT was determined on HEK 293 cells against cisplatin-induced cytotoxicity and oxidative stress. In vivo nephroprotective effect of NEERI KFT was determined against cisplatin-induced nephrotoxicity in Wistar rats, via assessing biochemical markers, antioxidant enzymes and inflammatory cytokines such as TNF-α, IL-1β, CASP-3, etc. The results showed that the compounds such as gallic acid, caffeic acid and ferulic acid are the major constituents of NEERI KFT, while network pharmacology analysis indicated a strong interaction between polyphenols and several genes (CASPs, ILs, AGTR1, AKT, ACE2, SOD1, etc.) involved in the pathophysiology of kidney disease. In vivo studies showed a significant (p < 0.05) ameliorative effect on biochemical markers and antioxidant enzymes (SOD, CAT, GSH, etc.), and regulates inflammatory cytokine (TNF-α, IL-1β, CASP-3) expression in kidney tissue. Hence, it can be concluded that NEERI KFT subsequently alleviates renal dysfunction mediated by cisplatin via attenuating oxidative and inflammatory stress, thus preserving the normalcy of kidney function.
Keywords: NEERI KFT, nephrotoxicity, cisplatin, network pharmacology, antioxidant activity, anti-inflammatory activity
Click on "Archives" to access the full archive of scientific preprints. You may use the categories and the search functionality to find select preprints you're interested in.
